Know Labs (KNWN) and Its Rivals Head-To-Head Analysis

Know Labs (OTCMKTS:KNWNGet Rating) is one of 28 public companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it compare to its peers? We will compare Know Labs to similar companies based on the strength of its earnings, analyst recommendations, profitability, valuation, dividends, risk and institutional ownership.

Earnings & Valuation

This table compares Know Labs and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Know Labs $120,000.00 -$25.36 million -1.79
Know Labs Competitors $2.66 billion $435.24 million 11.45

Know Labs’ peers have higher revenue and earnings than Know Labs. Know Labs is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.


This table compares Know Labs and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Know Labs N/A -968.13% -192.31%
Know Labs Competitors -3,288.70% 4.83% 1.80%

Volatility & Risk

Know Labs has a beta of 3.05, meaning that its share price is 205% more volatile than the S&P 500. Comparatively, Know Labs’ peers have a beta of 1.03, meaning that their average share price is 3% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and target prices for Know Labs and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Know Labs 0 0 1 0 3.00
Know Labs Competitors 154 692 956 28 2.47

Know Labs currently has a consensus price target of $7.00, suggesting a potential upside of 389.51%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 22.16%. Given Know Labs’ stronger consensus rating and higher possible upside, equities research analysts clearly believe Know Labs is more favorable than its peers.

Institutional and Insider Ownership

10.6% of Know Labs shares are held by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by institutional investors. 44.0% of Know Labs shares are held by insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.


Know Labs peers beat Know Labs on 7 of the 13 factors compared.

About Know Labs (Get Rating)

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Want More Great Investing Ideas?

Receive News & Ratings for Know Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Know Labs and related companies with's FREE daily email newsletter.